INTRODUCTION
The methionyl-tRNA synthetase (MARS) gene encodes cytoplasmic methionyl-tRNA synthetase (MetRS) responsible for catalyzing the ligation of methionine to tRNA [1] . MetRS belongs to a family of aminoacyl-tRNA synthetases that play critical roles in protein biosynthesis by charging tRNAs with their cognate amino acids [2] . Interstitial lung and liver disease (ILLD) (OMIM#615486) is caused by homozygous or compound heterozygous mutations in the MARS gene (156560) on chromosome 12q13 [3] [4] [5] . Heterozygous MARS mutations have been reported to be associated with autosomal dominant Charcot-Marie-Tooth disease (CMT) [6] [7] [8] [9] . The same MARS mutation may cause both ILLD and CMT [10] . MARS is also a candidate gene for hereditary spastic paraplegias (HSPs), a neuro-degenerative motor neuron disorder [11] . To date, no genetic changes other than missense variants have been reported in the literature. Here, we report a Chinese infant with lethal ILLD showing novel phenotypes such as kidney stones, acetabular dysplasia, prolonged fever, and extreme leukocytosis. Whole exome sequencing revealed a novel truncating variant together with a novel tri-nucleotide insertion in the MARS gene.
CASE REPORT
A five-month old female infant was presented with a failure to thrive, developmental delay, jaundice, and dark urine. She was born full-term with a normal birth weight (3100 g) after an uncomplicated first pregnancy and vaginal delivery. Weight gain and developmental milestones were normal until three months of age (weighted 6000 g), when she failed to thrive with a body weight of 5700 g at the age of 5 mo without the ability of rolling over.
At in-patient admission, this patient was 5.2 mo old with a body weight of 5500 g (2 nd percentile by WHO standards), length of 55 cm (lower than the 1 st percentile), and head circumference of 39 cm (2 nd percentile). This infant had prolonged low-grade fever, pulmonary effusion, diffuse interstitial lung disease, significant leukocytosis, high procalcitonin (PCT)/CRP levels, and required nasal oxygen therapy. Serial chest X-rays showed some improvement in pulmonary effusion, but no improvement in interstitial lung involvement ( Figure 1A ). After serial antibiotic treatments (ceftriaxone, cefoperazone + slubactam, meropenem, norvancomycin, and fluconazole), body temperature was normalized, oxygen therapy was no longer needed, and leukocytosis improved, however the interstitial lung disease stayed the same. After treatment with ursodeoxycholic acid and fat-soluble vitamins, cholestasis improved significantly (Table 1) .
The patient was discharged with normal oxygen saturation on room air without apparent respiratory distress or cough. A liver function test and complete blood count were normal at a 9.5 mo follow-up. However, the infant was admitted to a provincial level pediatric intensive care unit for acute respiratory distress at 11 mo of age and received mechanical ventilation. Despite treatment, she died of respiratory failure and hypoxic encephalopathy.
A genetic cause was suspected due to multiple system involvement, although a liver panel consisting of 41 genes (Table 2 ) related to liver diseases came back negative. Lysosomal storage disease was considered, but an enzyme panel for the screening of common lysosomal storage diseases was normal, as was the urine acidoglycoprotein level. This patient was enrolled for the undiagnosed disease patient program in our hospital, and whole exome sequencing was ordered. Compound heterozygous MARS gene variants, c.2158C>T/p.Gln720Stop and c.893_894insTCG/ p.Arg299dup, were detected. Presence of these mutations was confirmed with Sanger sequencing, and parental origins were ascertained. Both variants were not reported in the dbSNP137 (http://www. ncbi. nlm.nih.gov/snp/), 1000 Genome Database (http:// www.1000genomes.org/), and Exome Variant Server (http://evs.gs.washington.edu/EVS/). The c.2158C>T mutation was inherited from the healthy mother, which caused the change of a glutamine amino acid at position 720 to a stop codon, which was predicted to be diseasecausing by MutationTaster (http://www.mutationtaster. org). The tri-nucleotide insertion (c.893_894insTCG) inherited from her healthy father caused the insertion of a single amino acid (arginine) at position 299, which was predicted to be disease-causing by MutationTaster (Figure 2A ). The detailed genetic testing results and secondary findings are provided in Table 2 .
Liver biopsy results showed severe steatosis of hepatic cells with ballooning, lobular disarray, and cholestasis. Mild changes, such as fibrosis, lymphocyte infiltration, and bile duct proliferation, were seen within the portal region. Hepatic iron deposition was seen after iron staining, but copper staining was negative ( Figure 1C ). Sinosoids and Kupffer cells seemed normal. Immunohistochemical staining for hepatitis B surface antigen, core antigen, Epstein-Barr virus, and langerin cells were negative. Immunohistochemical staining for cholestasis-related proteins, such as BSEP, MDR3, MRP2, TJP2, and MYO5B, were all normal. After genetic diagnosis, we used a rabbit anti-MARS monoclonal antibody (purchased from http://www. abcam.cn, product code: ab180497) to perform immunohistochemical staining on paraffin-embedded liver biopsy samples. When compared to a normal liver sample (donated for liver transplantation), coarsely granular pigments within the cytoplasm were seen in the index patient sample.
Ultrasound examination revealed marked hepatomegaly (liver 4 cm below the right costal margin, and 5 cm below the xiphoid process) and reduced hepatic echogenicity. Hyper-echoic lesions consistent with stone formation were seen on both kidneys. Abdominal computed tomography scans showed hepatic steatosis and hyper-echoic lesions suggestive of kidney stones in the left kidney but not in the right kidney ( Figure 1B ). X-ray imaging of the skull was normal, as were the long bones of both arms and legs. X-ray imaging also picked up abnormally shallow hip sockets on both sides, which is suggestive of acetabular dysplasia or congenital hip dysplasia ( Figure 1B ). Other diagnostic evaluations are provided in Table 3 .
DISCUSSION
MetRS is one of 20 ubiquitously expressed enzymes essential for protein biosynthesis, and covalently links methionine with its cognate tRNA. Since initial reports of MARS gene mutations causing ILLD [3] and CMT [6] in 2013, a total of 34 cases of ILLD [4, 5, 10] and eight cases of CMT [7] [8] [9] [10] have been reported. Similar to previous reports, the patient in our case showed a failure to thrive, developmental delay, interstitial lung disease, liver involvement (hepatomegaly, cholestasis, hepatic steatosis, fibrosis, and iron deposition), anemia, and thrombocytosis. An active proliferation of bone marrow cells has been reported by Sun et al [5] . Our patient had marked leukocytosis (white blood cell count up to 71.7 × 10 9 /L), and a bone marrow biopsy showed extreme proliferation of bone marrow cells with few hemophagocytic cells. MetRS is also a component of a cytoplasmic multiaminoacyltRNA synthetase complex with multiple roles in immune response, inflammation, and tumorigenesis [12, 13] .
Prolonged low-grade fever, leukocytosis, thrombocytosis, and elevated c-reactive protein in this patient responded to intensive antibiotic treatment, and could be viewed as an exaggerated inflammatory or immune response to infection. Unlike previous reports of an arrest in red blood cell maturity [3, 5] , a bone marrow biopsy from this patient showed marked proliferation of normal erythrocyte precursors.
While aminoaciduria has been reported [3] , kidney stones have never been reported to be associated with a MARS mutation. No evidence of urinary tract infection, proteinuria, or organic aciduria was found in our case, and serum electrolytes with urea and creatinine were essentially normal. An evaluation of urinary citrate, calcium, and 24 h urine output in future ILLD cases might be necessary in order to rule out factors that promote renal stone formation [14] . Mutations in genes encoding mitochondrial seryl-tRNA synthetases have been reported to cause renal damage [15, 16] , but no association of cytoplasmic aminoacyl-tRNA synthetases, including MARS, have been reported. Since previously reported mutations were all non-synonymous in nature, severe mutations (such as a truncation or single amino acid insertion as in our case) may have caused some renal impairment leading to stone formation.
No skeletal abnormality has been reported, with the exception of two ILLD cases with delayed bone age [5] . Our case had marked acetabular dysplasia consistent with developmental hip dysplasia. Other than being female, this infant did not have other risk factors [17] , such as breach presentation upon delivery, local infection, or trauma. Whole exome sequencing did not reveal abnormalities in previously reported susceptible genes such as GDF5, TBX4, ASPN, , and PAPPA2 [18] . Hip dysplasia is associated with CMT [19] , Figure 1 Imaging and histopathological features. A: Contrast enhanced pulmonary CT scan (1-3), and chest X-ray (4) showing pulmonary effusion with marked interstitial lung involvement; B: Hyper-echoic lesions consistent with stone formation on ultrasonography (arrows; 1, right kidney; 2, left kidney) and non-contrast abdominal computed tomography scan (arrow, 3). Acetabular dysplasia (4, arrowhead showing abnormally shallow hip socket); C: Liver biopsy (all originally magnified principal images): severe steatosis of hepatic cells with ballooning, lobular disarray, and cholestasis (1-4), mild fibrosis (5), mild lymphocyte infiltration (4), bile duct proliferation (6) (7) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , and hepatic iron deposition (8) . MARS immunohistochemistry staining, coarsely granular pigments within the cytoplasm in the index patient (9), but not in samples of a healthy control (10) . MARS: Methionyl-tRNA synthetase gene. and the rate of hip dysplasia among children with CMT ranges from 6% to 8.1% [20] . Novarino et al [11] reported four cases of HSPs with compound heterozygous variants of the MARS gene in a family with infantile onset delayed motor milestones and disabilities upon crawling/walking. Two cases had bilateral Achilles contracture, one had scoliosis, but none had hip-joint abnormalities. A recent report of an ILLD case [10] with a p.Arg618Cys variant was also associated with CMT in a previous report [6] , indicating ILLD and CMT may share a similar disease-causing mechanism. All reported cases of CMT, ILLD, and HSPs associated with the MARS gene Severe mutations may have been responsible for the hip dysplasia, which could be an early manifestation of CMT in this patient. The c.2158C>T/p.Gln720Stop, which was inherited from the mother, caused the glutamine amino acid change at position 720, leading to a stop codon at a wellconserved α-helix bundle domain (anti-codon binding domain) of the methionyl-tRNA synthetase protein.
The tri-nucleotide insertion (c.893_894insTCG) with paternal origin caused the insertion of a single amino acid (arginine) at position 299 in the Rossmann fold domain (catalysis center). Nine out of 12 ILLD variants reported so far affected an amino acid in the Rossmann fold domain ( Figure 2B ). Arg299 is adjacent to the active methionine-binding site of human MetRS, which is surrounded by the amino acid residues Arg12, Leu13, Pro14, Thr257, Gly259, Tyr260, Asn297, and His301 [21] . All eight mutations from European ILLD cases were located in the Rossmann fold of the MARS protein. However, only one out of four mutations from Chinese cases carried mutations in the Rossmann fold domain, and the location of mutations among Chinese ILLD cases was significantly different from that of European ILLD cases (Fisher's exact = 0.018) ( Figure 2B ). Our case also suggested that severe mutations may lead to more organ/system involvement and severe outcomes.
In vivo yeast complementation assays were used to predict the effects of MARS variants, including 1852C>T/p.Arg618Cys [6] , c.920A>G/p.Tyr307Cys [10] and 1852C>T/p.Arg618Cys [10] . The in vitro aminoacylation assay with HEK293 cells was used to confirm the effects of c.1108T>C/p.Phe370Leu, and c.1568T>C/p.Ile523Thr MARS variants [3] . The effects of c.1031A>G/p.Tyr344Cys, c.1177G>A/p.Ala393Thr, c.1700C>T/p.Ser567Leu and c.1814A>T/p.Asp605Val were studied using the in vitro yeast aminoacylation assay [4] , and later by Comisso et al [22] using the E.
Coli-based aminoacylation assay. Further functional studies are needed to confirm the effects of variants in our case, as well as variants reported by others (c.2398C>A/p.Pro800Thr [7] , c.433G>A/p.Asp145Asn and c.2405T>C/p.Phe802Ser [5] ). Besides previously used methods, one may consider the use of animal models such as Drosophila and C. elegans to predict the pathogenicity of other aminoacyl-tRNA synthetase mutations [23] . There is currently no cure for ILLD, and thus treatment is only supportive. Provided that in vitro enzyme activity may partly be restored by increasing methionine [22] , methionine supplementation could be considered in studies of animal models, or possibly even in humans. However, plasma levels of methionine and its toxic product homocysteine should be closely monitored.
In conclusion, truncation and insertion variants in the MARS gene may cause ILLD, and phenotypes of ILLD may also include kidney stones, acetabular dysplasia, prolonged fever, and extreme leukocytosis.
ARTICLE HIGHLIGHTS

Case characteristics
A five-month old female infant presented with failure to thrive, developmental delay, jaundice, and dark urine.
Clinical diagnosis
Typical clinical findings and whole exome sequencing results led to a diagnosis of interstitial lung and liver disease (ILLD).
Differential diagnosis
Genetic cause was suspected due to multiple system involvement, but a liver panel consisting of 41 genes related to liver diseases came back negative. Lysosomal storage disease was considered, but an enzyme panel for screening common lysosomal storage diseases was normal, as was the urine acidoglycoprotein level.
Laboratory diagnosis
Laboratory findings were Cholestasis, anemia, abnormal blood coagulation profiled, thrombocytosis, and extreme leukocytosis. Whole exome sequencing revealed a novel truncating variant (c.2158C>T/p.Gln720Stop) and a novel tri-nucleotide insertion (c.893_894insTCG) in the methionyl-tRNA synthetase (MARS) gene.
Imaging diagnosis
X-ray, computed tomography scan, and ultrasound imaging revealed interstitial lung disease, hepatomegaly, kidney stones, and acetabular dysplasia.
Pathological diagnosis
Liver biopsy results showed severe hepatic steatosis, hepatic cells ballooning, lobular disarray, cholestasis, iron deposition, and mild fibrosis/lymphocyte infiltration/bile duct proliferation within the portal region.
Treatment
Ursodeoxycholic acid, fat-soluble vitamins, antibiotics, oxygen therapy, and supportive treatment.
Related reports
Previous reports of ILLD were associated with biallelic missense mutations in the MARS gene. Phenotypes, such as kidney stones, acetabular dysplasia, prolonged fever, and extreme leukocytosis have never been reported to be associated with ILLD.
Term explanation
ILLD is interstitial lung and liver disease caused by homozygous or compound heterozygous mutations in the MARS gene. Typical findings in ILLD include failure to thrive, developmental delay, interstitial lung disease, liver involvement (hepatomegaly, cholestasis, hepatic steatosis, fibrosis, and iron deposition), anemia, and thrombocytosis.
